ASSETS HELD-FOR-SALE (Details) (USD $) In Millions, unless otherwise specified	Dec. 31, 2014	Mar. 31, 2014	Dec. 31, 2013
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Goodwill		$ 600	$ 550
Total assets held-for-sale	109		7,420
Short-term borrowings and current portion of long-term debt			27
Total liabilities related to assets held-for-sale			4,931
The Medicines Company and Valeant [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Inventories	38
Goodwill	19
Other intangible assets	52
Total assets held-for-sale	109
AstraZeneca [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Receivables			83
Inventories			163
Deferred income taxes - current			125
Prepaid expenses and other			20
Property, plant and equipment			678
Goodwill			550
Other intangible assets			5,682
Other assets			119
Total assets held-for-sale			7,420
Short-term borrowings and current portion of long-term debt			27
Accounts payable			30
Accrued expenses			148
Deferred income - current			352
Accrued rebates and returns			81
Deferred income - noncurrent			3,319
Deferred income taxes - noncurrent			946
Other liabilities			28
Total liabilities related to assets held-for-sale			$ 4,931